Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
73.51
UNCHANGED
Streaming Delayed Price
Updated: 4:15 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week...
Via
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
Analyzing Gilead Sciences's Unusual Options Activity
August 11, 2021
On Wednesday, shares of Gilead Sciences (NASDAQ:GILD) saw...
Via
Benzinga
Analyzing Gilead Sciences's Unusual Options Activity
August 06, 2021
Gilead Sciences (NASDAQ:GILD) shares experienced unusual o...
Via
Benzinga
Large Cap Biopharma Stocks provide Growth and Value
August 16, 2021
The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Stocks That Hit 52-Week Highs On Monday
August 16, 2021
Before 10 a.m. ET on Monday, 71 companies hit new 52-week highs. Highlights: Apple (NASDAQ:AAPL) was the largest firm on a market cap basis to set a new 52-week...
Via
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
What To Know About Rand Paul Failing To Disclose Gilead Stock Purchase For 16 Months
August 12, 2021
Stock transactions by members of the U.S. Congress and their spouses have been a hot topic over the last several years. A transaction disclosed late Wednesday is drawing heavy...
Via
Benzinga
Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program
August 11, 2021
Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program
Via
News Direct
Exposures
COVID-19
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
August 09, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Fake Versions Of Gilead's HIV Drugs Are In Circulation In US
August 06, 2021
Gilead Sciences Inc (NASDAQ: GILD) warned Thursday that its original HIV treatments Biktarvy and Descovy had been replaced by fake versions at some pharmacies....
Via
Benzinga
3 Biotech Stocks That Could Make You Richer in August (and Beyond)
August 05, 2021
All three have blockbuster products already on the market.
Via
The Motley Fool
This High-Risk, High-Reward Biotech Could Make COVID Less Deadly -- and Make Investors Money
August 04, 2021
An effective oral antiviral therapy for the coronavirus may be around the corner.
Via
The Motley Fool
Exposures
COVID-19
International AIDS Society Leaders on the Future of HIV Prevention and Treatment
August 03, 2021
International AIDS Society Leaders on the Future of HIV Prevention and Treatment
Via
News Direct
Exposures
COVID-19
Why Investors Should Like BioNTech's Latest Deal With Gilead
July 31, 2021
There are several pluses for BioNTech in the deal.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
Gilead Sciences (GILD) Q2 2021 Earnings Call Transcript
July 30, 2021
GILD earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
July 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Gilead Sciences Exceeds Expectations As Remdesivir Success Cushions Slump In HIV Franchise
July 30, 2021
Gilead Sciences Inc (NASDAQ: GILD) reported Q2 sales of $6.2 billion +21% Y/Y, beating the consensus estimate of $6.07 billion, helped by solid demand for COVID-19...
Via
Benzinga
Amazon Earnings Could Take the Market Down with it
July 29, 2021
While we've seen sell-offs occur on recent positive earnings surprises, few have been dramatic and none has been as consequential as AMZN could be tomorrow.
Via
Talk Markets
Recap: Gilead Sciences Q2 Earnings
July 29, 2021
Shares of Gilead Sciences (NASDAQ:GILD) decreased 0.8% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 68.47% year...
Via
Benzinga
Gilead Earnings Top Views; Biotech Giant Narrows Guidance
July 29, 2021
Gilead earnings modestly beat Q2 views with the biotech giant narrowing its full-year EPS target range. Gilead dipped late.
Via
Investor's Business Daily
Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients
July 29, 2021
The FDA extended the Emergency Use Authorization (EUA) for Eli Lilly And Co's (NYSE: LLY) and Incyte Corporation's (NASDAQ: INCY) rheumatoid...
Via
Benzinga
Exposures
COVID-19
Product Safety
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Prioritizing the Needs of the Black LGBTQ+ Community in an Innovative HIV Trial
July 27, 2021
Prioritizing the Needs of the Black LGBTQ+ Community in an Innovative HIV Trial
Via
News Direct
A Look Into Gilead Sciences Price Over Earnings
July 27, 2021
Looking into the current session, Gilead Sciences Inc. (NASDAQ:GILD) shares are trading at $68.78, after a 0.1% increase. Moreover, over the past month, the stock...
Via
Benzinga
Gilead Ordered To Pay Attorney Fees In Shareholder Lawsuit
July 26, 2021
Gilead Sciences Inc. (NYSE: GILD) was ordered to pay about $1.8 million late last week in attorney’s fees and legal expenses to shareholders who sued the company after...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Understanding Gilead Sciences's Unusual Options Activity
July 26, 2021
Shares of Gilead Sciences (NASDAQ:GILD) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $68.81. Sentiment: BULLISH...
Via
Benzinga
Healthcare ETFs in Focus as Q2 Earnings Unfold
July 22, 2021
Let’s dig deeper into the earnings picture of the companies which will drive the performance of healthcare funds in the coming days.
Via
Talk Markets
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Arcus Surges As Executive Transfer Could Signal Deeper Gilead Partnership
July 20, 2021
An Arcus executive jumped ship for a role at Gilead, but RCUS stock popped Tuesday on expectations for a closer relationship.
Via
Investor's Business Daily
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.